Holland, PA, United States of America

Jean-Philippe Meyer


Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 1999-2002

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Inventor Jean-Philippe Meyer: Pioneering Innovations in Pharmaceutical Compounds

Introduction

Jean-Philippe Meyer is a notable inventor based in Holland, PA, USA, recognized for his significant contributions to the field of biochemical innovations. With a portfolio that includes five patents, Meyer has demonstrated exceptional expertise in developing compounds aimed at addressing critical health challenges, particularly those related to bone health.

Latest Patents

Meyer’s latest patents include groundbreaking innovations such as "Dialkyl ureas as calcitonin mimetics." This invention describes dialkyl urea compounds that function as calcitonin mimetics, which are valuable in treating diseases associated with bone resorption. Furthermore, these calcitonin mimetics play a crucial role in assays designed to determine calcitonin receptor activity.

Another notable patent is "Combinatorial libraries of bicyclic guanidine derivatives and compounds therein." This invention introduces a streamlined method for the combinatorial synthesis and screening of bicyclic guanidine compounds. The invention not only outlines the compounds produced through this synthesis but also details their potential applications.

Career Highlights

Throughout his career, Jean-Philippe Meyer has been associated with leading research organizations where he has applied his extensive knowledge in biochemistry. Notable companies he has worked with include Zymogenetics, Inc. and Trega Biosciences, Inc. These experiences have allowed him to refine his skills in developing novel therapeutic compounds and enhancing pharmaceutical research.

Collaborations

Meyer has collaborated with esteemed professionals in the field, including coworkers John M. Ostresh and Charles R. Petrie. These partnerships have fostered an environment of innovation, leading to advancements in pharmaceutical technologies and the development of sophisticated compounds that address various medical conditions.

Conclusion

Jean-Philippe Meyer stands out as a significant figure in the world of inventions and patents, particularly in the pharmaceutical domain. His pioneering work on calcitonin mimetics and combinatorial libraries showcases the potential for innovative solutions to pressing health issues. As researchers and companies continue to explore new therapeutic avenues, Meyer's contributions remain integral to the advancement of medical treatments and innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…